Filing Flows › Cannapharmarx (CPMD) › Q2 2026 › vs Q1 2026
Cannapharmarx (CPMD) Q2 2026 vs Q1 2026 (quarter over quarter)
Cannapharmarx's revenue fell $351K (-56%) from $627K in Q1 2026 to $276K in Q2 2026.
Cannapharmarx, Q2 2026: revenue $276K (+19% year over year), operating margin -137.1%, net loss $1.9M, operating cash flow −$127K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $276K | $627K | −$351K | -56% |
| Net loss | $1.9M | $382K | $1.5M | +400% |
| Costs & expenses | $2.2M | $1.3M | $875K | +67% |
| Operating costs | $655K | $1.3M | −$655K | -50% |
| Interest & other, net | $1.5M | −$300K | $1.8M | — |
| Cost of revenue | $415K | $1.0M | −$622K | -60% |
| General & admin | $83K | $36K | $47K | +131% |
| Other operating costs | $158K | $237K | −$79K | -34% |
| Operating cash sources | $1.9M | $366K | $1.5M | +421% |
| Working capital & other | $1.8M | $123K | $1.7M | 15× |
| Cash used in operations | $127K | $244K | −$116K | -48% |
| Net loss absorbed | $1.9M | $382K | $1.5M | +400% |
Questions
How much did Cannapharmarx's revenue grow quarter over quarter in Q2 2026?
Cannapharmarx's revenue fell $351K (-56%) from $627K in Q1 2026 to $276K in Q2 2026.